Épidémiologie et physiopathologie du carcinome hépatocellulaire (notice n° 664335)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03328cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121193625.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Nguyen, Thi Thu Nga |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Épidémiologie et physiopathologie du carcinome hépatocellulaire |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 9 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Le cancer primitif du foie (CPF) est le sixième cancer en termes d’incidence et la quatrième cause de décès par cancer dans le monde. Son incidence est variable selon les régions géographiques reflétant la disparité des facteurs de risque. Alors que son incidence a tendance à diminuer dans les pays en voie de développement, elle a augmenté dans les pays développés ces dernières décennies. Avec la mise en œuvre des programmes de vaccination contre l’hépatite B et de traitement de l’hépatite C, l’incidence de CPF lié aux hépatites virales tend à décliner. En France, l’alcool reste la première cause d’hépatopathie chronique sous-jacente au carcinome hépatocellulaire (CHC), principale forme de CPF, et la stéatopathie non alcoolique devrait bientôt devenir la seconde cause. Malgré des progrès remarquables dans la prise en charge du CHC, du fait d’un diagnostic généralement trop tardif, la survie médiane est de moins d’un an. Un meilleur contrôle des facteurs de risque et la mise en œuvre d’un dépistage systématique chez les patients à haut risque sont les axes majeurs d’amélioration du pronostic. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Primitive liver cancer is the sixth most commonly diagnosed cancer and the fourth leading cause of cancer-related death worldwide. Its incidence is heterogeneous because of the variable prevalence of underlying risk factors. While the incidence tends to decrease in low economic resource countries, its incidence and mortality are rapidly rising in the developed regions. With the implementation of hepatitis B vaccination and hepatitis C treatment programs worldwide, the epidemiology of hepatocellular carcinoma is shifting away from a disease predominated by viral hepatitis to an increasing proportion of cases which are now attributable to non-alcoholic fatty liver disease (NAFLD). In France, alcohol is the leading cause of the underlying chronic liver disease to liver cancer but this picture could be changed in the future due to a marked growing prevalence of NAFLD which affects about 20% of the French population. Despite remarkable progress in diagnosis and treatment of primary liver cancer, its prognosis remains very poor with a median survival less than 12 months. This highlights the key role of primary prevention with a better control of risk factors and of an efficient monitoring of liver cancer in at high-risk patients. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hépatite virale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | NAFLD |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | carcinome hépatocellulaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | surveillance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cirrhose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hepatocellular carcinoma |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | NAFLD |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | viral hepatitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | surveillance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cirrhosis |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ganne-Carrié, Nathalie |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 27 | N° Supp 1 | 2020-04-15 | p. 9-16 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2020-HS1-page-9?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2020-HS1-page-9?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux